Cargando…
UK Dermatology Clinical Trials Network’s STOP GAP trial (a multicentre trial of prednisolone versus ciclosporin for pyoderma gangrenosum): protocol for a randomised controlled trial
BACKGROUND: Pyoderma gangrenosum (PG) is a rare inflammatory skin disorder characterised by painful and rapidly progressing skin ulceration. PG can be extremely difficult to treat and patients often require systemic immunosuppression. Recurrent lesions of PG are common, but the relative rarity of th...
Autores principales: | Craig, Fiona F, Thomas, Kim S, Mitchell, Eleanor J, Williams, Hywel C, Norrie, John, Mason, James M, Ormerod, Anthony D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3423010/ https://www.ncbi.nlm.nih.gov/pubmed/22540770 http://dx.doi.org/10.1186/1745-6215-13-51 |
Ejemplares similares
-
Ciclosporin compared with prednisolone therapy for patients with pyoderma gangrenosum: cost‐effectiveness analysis of the STOP GAP trial
por: Mason, J.M., et al.
Publicado: (2017) -
Comparison of the two most commonly used treatments for pyoderma gangrenosum: results of the STOP GAP randomised controlled trial
por: Ormerod, Anthony D, et al.
Publicado: (2015) -
Comparison of the two most commonly used treatments for pyoderma
gangrenosum: results of the STOP GAP randomised controlled trial
Publicado: (2017) -
Penile pyoderma gangrenosum
por: Philip, Mariam, et al.
Publicado: (2013) -
Pyoderma gangrenosum: An update
por: Bhat, Ramesh M.
Publicado: (2012)